news
Quantum Genomics expands its US presence
5 February 2016 | By Victoria White
Quantum Genomics has established a US Clinical Advisory Board of renowned cardiologists and cardiovascular researchers...
List view / Grid view
Genomics
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
news
Non-coding RNA helps suppress breast cancer
2 February 2016 | By Victoria White
A team of scientists from Bath, Cambridge and the USA has identified a piece of non-coding RNA that stops cells turning cancerous...
news
Epigenome mining leads to medulloblastoma discovery
29 January 2016 | By Victoria White
Researchers have identified the cells that likely give rise to the brain tumour subtype Group 4 medulloblastoma, removing a barrier to developing more effective targeted therapies....
news
Myeloma UK and the SGC in first-of-its-kind collaboration
27 January 2016 | By Victoria White
Myeloma UK and the SGC have entered into an open-access research partnership to discover drug targets for myeloma using structural biology and chemical proteomics...
news
UC Berkeley researchers improve CRISPR-Cas9 gene editing technology
21 January 2016 | By Victoria White
The researchers have announced a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60% when replacing a short stretch of DNA with another...
news
Registration has now opened for Oxford Global’s 17th Annual Drug Discovery Leaders Summit
13 January 2016 | By Oxford Global
Oxford Global Conferences are proud to present the successful 17th Annual Drug Discovery Leaders Summit and co-located 4th Annual Discovery Chemistry & Drug Design Congress taking place on the 13th & 14th June in Berlin...
news
Discovery of novel targets and therapeutics for Crohn’s disease
7 January 2016 | By Nicholas Jackson
Enterome announces collaboration with Johnson & Johnson Innovation focused on the discovery of novel targets and therapeutics for Crohn’s disease...
news
Vertex and Genomics enter target pathway collaboration
4 January 2016 | By Victoria White
Vertex Pharmaceuticals is to use Genomic’s integrated database and state-of-the-art analysis tools to identify target therapeutic pathways...
whitepaper
eBook: Detect Nucleic Acids and Proteins Like a Pro
Download your free eBook to discover novel assays to advance your nucleic acid and protein detection...
article
Analysing recombinant proteins by mass spectrometry
The drug discovery landscape is changing: no longer limited to big pharma, it is now within reach of academics and small consortia alike. Regardless of the setting, drug discovery requirements are always the same: strong biological theory, good chemical starting material and high quality protein samples from which to determine…
article
Drug Target Review – Issue #4 2015
3 December 2015 | By Drug Target Review
Included in this issue: Biomarkers, Mass Spectrometry, Target Validation, Drug Development, Personalised Medicines, Next-Generation Sequencing, Protein Expression, Companion Diagnostics, and much more...
article
Mass Spectrometry In-Depth Focus 2015
In this Mass Spectrometry In-Depth Focus: Michelle M. Hill from University of Queensland discusses Mass spectrometric and systems biology approaches in drug target discovery, and Nicola Burgess-Brown, Rod Chalk, Claire Strain-Damerell and Pravin Mahajan from the Structural Genomics Consortium look at analysing recombinant proteins by mass spectrometry...
webinar
Genomic support for target selection and validation in drug development: design of a new genotyping array
22 November 2015 | By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
news
PPF could limit the spread of glioblastoma multiforme
13 November 2015 | By Victoria White
PPF works to limit the spread of glioblastoma multiforme by targeting a protein called TROY...
news
Boehringer Ingelheim pledges EUR 11 billion to R&D
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
